Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
Simone I. Richardson, Bronwen E. Lambson, Andrew R. Crowley, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 12, pp. e1008064-e1008064
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

FcγR Binding and ADCC Activity of Human IgG Allotypes
Steven W. de Taeye, Arthur E. H. Bentlage, Mirjam M. Mebius, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 142
Antiviral neutralizing antibodies: from in vitro to in vivo activity
Dennis R. Burton
Nature reviews. Immunology (2023) Vol. 23, Iss. 11, pp. 720-734
Open Access | Times Cited: 61
Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 30
Broadly Neutralizing Antibodies for HIV-1 Prevention
Stephen R. Walsh, Michael S. Seaman
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 66
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
Taishi Onodera, Shunsuke Kita, Yu Adachi, et al.
Immunity (2021) Vol. 54, Iss. 10, pp. 2385-2398.e10
Open Access | Times Cited: 56
Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
Eleanor C. Semmes, Itzayana G. Miller, Courtney E. Wimberly, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 16
Open Access | Times Cited: 47
Maternal immune protection against infectious diseases
Stephanie N. Langel, Maria Blasi, Sallie R. Permar
Cell Host & Microbe (2022) Vol. 30, Iss. 5, pp. 660-674
Open Access | Times Cited: 40
Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains
Leoni Abendstein, Douwe J. Dijkstra, Rayman T.N. Tjokrodirijo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission
Eleanor C. Semmes, Itzayana G. Miller, Nicole Rodgers, et al.
JCI Insight (2023) Vol. 8, Iss. 13
Open Access | Times Cited: 23
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
Thach H. Chu, Andrew R. Crowley, Iara M. Backes, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 2, pp. e1008083-e1008083
Open Access | Times Cited: 68
Coming together at the hinges: Therapeutic prospects of IgG3
Thach H. Chu, Edward F. Patz, Margaret E. Ackerman
mAbs (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19
Yun Shan Goh, Jean‐Marc Chavatte, Jieling Lim, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 2, pp. 100193-100193
Open Access | Times Cited: 47
Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities
Yaozong Chen, Lulu Sun, Irfan Ullah, et al.
Science Advances (2022) Vol. 8, Iss. 28
Open Access | Times Cited: 36
IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding
Marcus J. Bolton, Jefferson Santos, Claudia P. Arevalo, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 35
Open Access | Times Cited: 17
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
Nadège Nziza, Yixiang Deng, Lianna Wood, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Broadly neutralizing antibodies for HIV-1 prevention and therapy
Boris Jülg, Dan H. Barouch
Seminars in Immunology (2021) Vol. 51, pp. 101475-101475
Closed Access | Times Cited: 34
Potent TRIM21 and complement-dependent intracellular antiviral immunity requires the IgG3 hinge
Stian Foss, Alexandra Jonsson, Maria Bottermann, et al.
Science Immunology (2022) Vol. 7, Iss. 70
Open Access | Times Cited: 23
Next-generation bNAbs for HIV-1 cure strategies
Angela I. Schriek, Yoann Aldon, Marit J. van Gils, et al.
Antiviral Research (2023) Vol. 222, pp. 105788-105788
Open Access | Times Cited: 12
Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques
Natasha S. Kelkar, Benjamin S. Goldberg, Jérémy Dufloo, et al.
mBio (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 4
Broadly neutralizing antibodies for HIV prevention: a comprehensive review and future perspectives
Sharana Mahomed
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 4
Population-specific diversity of the immunoglobulin constant heavy G chain (IGHG) genes
Arman Bashirova, Wanjing Zheng, Marjan Akdag, et al.
Genes and Immunity (2021) Vol. 22, Iss. 7-8, pp. 327-334
Open Access | Times Cited: 24
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
Angela I. Schriek, Marlies M. van Haaren, Meliawati Poniman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
Cathrine Scheepers, Valerie Bekker, Colin Anthony, et al.
Cell Reports (2020) Vol. 33, Iss. 8, pp. 108430-108430
Open Access | Times Cited: 24
Targeting Fc effector function in vaccine design
Simone I. Richardson, Penny L. Moore
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 467-477
Closed Access | Times Cited: 21
HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
Simone I. Richardson, Frances Ayres, Nelia P. Manamela, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top